Pharmaceutical Business review

unithink Expands US, Europe, Asian Operations

Based on the growth of the clinical research market and the demand for outsourced eClinical services, unithink claimed that it has increased its operations by 50% in the US, and by 30% in Europe and Asia.

unithink has added new positions in the fields of business development, project management, quality control, data management and information management. Client base, enhanced service offerings, expanding internal departments and more advanced technologies are the reasons for unithink’s expansion.

Rudiger Mees, CEO of unithink, said: “We’re on track with a plan to increase our customer base and revenues on a global basis, as more pharmaceutical, biotechnology and medical device companies are looking for solutions to access and utilise data across all departments.”